Follicular lymphoma trials in Australia

In Australia 18 Also abroad 188

18 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Where
East Melbourne
Age
18 years and over
People
130 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06806033 · EU 2024-516791-15-00
Phase 1/2Taking people
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Where
Adelaide, Box Hill, Townsville
Age
18 years and over
People
280 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00
Phase 2/3Taking people
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Where
Box Hill
Age
18 years and over
People
960 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07634471 · EU 2025-522777-10-00
Phase 1/2Taking people
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Where
Nedlands, Richmond
Age
18 years and over
People
180 worldwide
Run by
ModeX Therapeutics, An OPKO Health Company
See details and how to joinNCT07249905
Phase 1Taking people
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Where
Melbourne, VIC, Nedlands
Age
18 years and over
People
215 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07101328 · EU 2025-524180-20-00
Phase 1Taking people
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Where
Adelaide, Hobart, Perth, Westmead
Age
18 years and over
People
140 worldwide
Run by
Iksuda Therapeutics Ltd.
See details and how to joinNCT05365659
Phase 1Taking people
A Study of ARC-02 in B-cell NHL
Where
Clayton, Melbourne, Nedlands, Southport
Age
18 years and over
People
140 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00
Phase 3Taking people
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Where
Clayton, Darlinghurst, Garran, Heidelberg, Macquarie University, Nedlands
Age
18 years to 130 years
People
1,018 worldwide
Run by
AstraZeneca
See details and how to joinNCT06549595 · EU 2023-510098-33-01
Phase 2Taking people
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Where
Heidelberg, Kogarah, Macquarie University, Nedlands
Age
18 years and over
People
270 worldwide
Run by
AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00
Phase 3Taking people
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Where
Benowa, East Melbourne, Hobart, Liverpool, Waratah
Age
18 years and over
People
580 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06149286 · EU 2022-503092-28-00
Phase 3Taking people
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Where
Auchenflower, Bedford Park, Clayton, East Melbourne, Liverpool, Melbourne
Age
18 years and over
People
822 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06091254 · EU 2022-502660-20-00
Phase 1/2Taking people
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Where
Concord, Fitzroy, Heidelberg, Melbourne, Nedlands, Waratah, West Perth, Woolloongabba
Age
18 years and over
People
689 worldwide
Run by
BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00
Phase 1/2Taking people
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Where
Melbourne, Nedlands
Age
18 years and over
People
174 worldwide
Run by
AstraZeneca
See details and how to joinNCT06542250
Phase 1/2Taking people
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Where
Melbourne, Nedlands, Perth
Age
18 years and over
People
270 worldwide
Run by
Lyell Immunopharma, Inc.
See details and how to joinNCT05826535
Phase 3Taking people
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Where
Adelaide, Heidelberg, Hobart, Malvern, Perth, Westmead
Age
18 years and over
People
400 worldwide
Run by
Celgene
See details and how to joinNCT06911502 · EU 2024-519152-82-00
No phaseTaking people
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
Where
Kingswood, Malvern, Waratah
Age
18 years and over
People
700 worldwide
Run by
AbbVie
See details and how to joinNCT06830759
Phase 1Taking people
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Where
Bedford Park, Buderim, Darlinghurst, Southport, Subiaco, Wollongong, Woolloongabba
Age
18 years and over
People
168 worldwide
Run by
OncoNano Medicine, Inc.
See details and how to joinNCT06022029
Phase 1/2Taking people
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
Where
Camperdown, Melbourne, Nedlands
Age
18 years and over
People
120 worldwide
Run by
CRISPR Therapeutics AG
See details and how to joinNCT05643742